ILS-920: A Rapamycin Analog for Ischemic Stroke

Natural Products: Discourse, Diversity, and Design

Volumn , Issue , 2014, Pages 469-481

  Graziani, Edmund I ^a  

^a PFIZER INC   (United States)

Author keywords

ILS 920; Ischemic stroke; Nonimmunosuppressive rapalog; Permanent middle cerebral artery occlusion (MCAO)

Indexed keywords

EID: 84926430190     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118794623.ch25     Document Type: Chapter

References (27)

1. Sehgal, S. N.; Baker, H.; Vezina, C. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J. Antibiot. (Tokyo). 1975, 28, 727-732.
2. Graziani, E. I. Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs. Nat. Prod. Rep. 2009, 26, 602-609.
3. Sehgal, S. N. Sirolimus: its discovery, biological properties, and mechanism of action. Transplant. Proc. 2003, 35, 7S-14S.
4. Hudes, G.; Carducci, M.; Tomczak, P.; Dutcher, J.; Figlin, R.; Kapoor, A.; Staroslawska, E.; Sosman, J.; McDermott, D.; Bodrogi, I.; Kovacevic, Z.; Lesovoy, V.; Schmidt-Wolf, I. G.; Barbarash, O.; Gokmen, E.; O'Toole, T.; Lustgarten, S.; Moore, L.; Motzer, R. J. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N. Engl. J. Med. 2007, 356, 2271-2281.
5. Abraham, R. T.; Gibbons, J. J.; Graziani, E. I. Chapter 17-Chemistry and pharmacology of rapamycin and its derivatives. In The Enzymes; Michael, N. H., Fuyuhiko, T., Eds.; Academic Press, 2010; Vol 27, p 329-366.
6. Harding, H. P.; Ron, D. Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes 2002, 51 (Suppl 3), S455-S461.
7. Edlich, F.; Fischer, G. Pharmacological targeting of catalyzed protein folding: the example of peptide bond cis/trans isomerases. Handb. Exp. Pharmacol. 2006, 172 359-404.
8. Sabers, C. J.; Martin, M. M.; Brunn, G. J.; Williams, J. M.; Dumont, F. J.; Wiederrecht, G.; Abraham, R. T. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J. Biol. Chem. 1995, 270, 815-822.
9. Choi, J.; Chen, J.; Schreiber, S. L.; Clardy, J. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science 1996, 273, 239-242.
10. Heitman, J.; Movva, N. R.; Hall, M. N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science. 1991, 253, 905-909.
11. Abraham, R. T. TOR signaling: an Odyssey from cellular stress to the cell growth machinery. Curr. Biol. 2005, 15, R139-R141.
12. Steiner, J. P.; Connolly, M. A.; Valentine, H. L.; Hamilton, G. S.; Dawson, T. M.; Hester, L.; Snyder, S. H. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat. Med. 1997, 3, 421-428.
13. Gold, B. G.; Densmore, V.; Shou, W.; Matzuk, M. M.; Gordon, H. S. Immunophilin FK506- binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J. Pharmacol. Exp. Ther. 1999, 289, 1202-1210.
14. Edlich, F.; Weiwad, M.; Wildemann, D.; Jarczowski, F.; Kilka, S.; Moutty, M. C.; Jahreis, G.; Lucke, C.; Schmidt, W.; Striggow, F.; Fischer, G. The specific FKBP38 inhibitor N-(N′,N′- dimethylcarboxamidomethyl)cycloheximide has potent neuroprotective and neurotrophic properties in brain ischemia. J. Biol. Chem. 2006, 281, 14961-14970.
15. Liu, D.; McIlvain, H. B.; Fennell, M.; Dunlop, J.; Wood, A.; Zaleska, M. M.; Graziani, E. I.; Pong, K. Screening of immunophilin ligands by quantitative analysis of neurofilament expression and neurite outgrowth in cultured neurons and cells. J. Neurosci. Methods. 2007, 163, 310-320.
16. Ruan, B.; Pong, K.; Jow, F.; Bowlby, M.; Crozier, R. A.; Liu, D.; Liang, S.; Chen, Y.; Mercado, M. L.; Feng, X.; Bennett, F.; von Schack, D.; McDonald, L.; Zaleska, M. M.;Wood, A.; Reinhart, P. H.; Magolda, R. L.; Skotnicki, J.; Pangalos, M. N.; Koehn, F. E.; Carter, G. T.; Abou-Gharbia, M.; Graziani, E. I. Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 33-38.
17. Liang, S.; Liu, D.; Chen, Y.; Mercado, M. L. T.; Graziani, E. I.; Reinhart, P. H.; Pangalos, M. N.; Wood, A.; Zaleska, M. M. Society for Neuroscience Annual Meeting, Chicago, IL, 2009.
18. Graziani, E. I. Chapter 14-Uncoupling neuroprotection from immunosuppression: the discovery of ILS-920. In Accounts in Drug Discovery; The Royal Society of Chemistry, 2011; p 316-331.
19. Tamura, A.; Graham, D. I.; McCulloch, J.; Teasdale, G. M. Focal cerebral ischaemia in the rat: 1. description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1981, 1, 53-60.
20. Montoya, C. P.; Campbell-Hope, L. J.; Pemberton, K. D.; Dunnett, S. B. The "staircase test": a measure of independent forelimb reaching and grasping abilities in rats. J. Neurosci. Methods 1991, 36, 219-228.
21. Gavrieli, Y.; Sherman, Y.; Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 1992, 119, 493-501.
22. Mullen, R. J.; Buck, C. R.; Smith, A. M. NeuN, a neuronal specific nuclear protein in vertebrates. Development. 1992, 116, 201-211.
23. Kosik, K. S.; Orecchio, L. D.; Bruns, G. A. P.; Benowitz, L. I.; MacDonald, G. P.; Cox, D. R.; Neve, R. L. Human GAP 43: Its deduced amino acid sequence and chromosomal localization in mouse and human. Neuron. 1988, 1, 127-132.
24. Frey, D.; Laux, T.; Xu, L.; Schneider, C.; Caroni, P. Shared and unique roles of Cap23 and Gap43 in actin regulation, neurite outgrowth, and anatomical plasticity. J. Cell Biol. 2000, 149, 1443-1454.
25. Araki, K.; Turner, A. P.; Shaffer, V. O.; Gangappa, S.; Keller, S. A.; Bachmann, M. F.; Larsen, C. P.; Ahmed, R. mTOR regulates memory CD8 T-cell differentiation. Nature. 2009, 460, 108-112.
26. Harrison, D. E.; Strong, R.; Sharp, Z. D.; Nelson, J. F.; Astle, C. M.; Flurkey, K.; Nadon, N. L.; Wilkinson, J. E.; Frenkel, K.; Carter, C. S.; Pahor, M.; Javors, M. A.; Fernandez, E.; Miller, R. A. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009, 460, 392-395.
27. Li, J. W.-H.; Vederas, J. C. Drug discovery and natural products: end of an era or an endless frontier? Science 2009, 325, 161-165.